IIIM-368/15

N/A

Report date: 2025/03/20 15:01:02
NME

Base Information

Drug NameIIIM-368/15
Drug Alias Namemeriolin analogs (Indian Institute of Integrative Medicine)Cdk-2/Cdk-9 inhibitor (Indian Institute of Integrative Medicine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 9
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndian Institute of Integrative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesIndian Institute of Integrative Medicine
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A